Medigus Ltd Adr Stock Cash And Equivalents
MDGSDelisted Stock | USD 1.73 0.01 0.58% |
Medigus Ltd ADR fundamentals help investors to digest information that contributes to Medigus' financial success or failures. It also enables traders to predict the movement of Medigus Stock. The fundamental analysis module provides a way to measure Medigus' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medigus stock.
Medigus |
Medigus Ltd ADR Company Cash And Equivalents Analysis
Medigus' Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current Medigus Cash And Equivalents | 24.75 M |
Most of Medigus' fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medigus Ltd ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
CompetitionIn accordance with the recently published financial statements, Medigus Ltd ADR has 24.75 M in Cash And Equivalents. This is 96.98% lower than that of the Health Care Equipment & Supplies sector and 95.56% lower than that of the Health Care industry. The cash and equivalents for all United States stocks is 99.08% higher than that of the company.
Medigus Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medigus' direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Medigus could also be used in its relative valuation, which is a method of valuing Medigus by comparing valuation metrics of similar companies.Medigus is currently under evaluation in cash and equivalents category among its peers.
Medigus Fundamentals
Return On Equity | -0.31 | |||
Return On Asset | -0.0663 | |||
Profit Margin | (0.13) % | |||
Operating Margin | (0.09) % | |||
Current Valuation | 65.3 M | |||
Shares Outstanding | 1.89 M | |||
Shares Owned By Institutions | 0.29 % | |||
Number Of Shares Shorted | 4.18 K | |||
Price To Earning | 33.86 X | |||
Price To Book | 0.15 X | |||
Price To Sales | 0.04 X | |||
Revenue | 91.86 M | |||
Gross Profit | 4.8 M | |||
EBITDA | (11.99 M) | |||
Net Income | (10.1 M) | |||
Cash And Equivalents | 24.75 M | |||
Cash Per Share | 1.01 X | |||
Total Debt | 10.13 M | |||
Debt To Equity | 0.27 % | |||
Current Ratio | 1.38 X | |||
Book Value Per Share | 18.67 X | |||
Cash Flow From Operations | (5.66 M) | |||
Short Ratio | 0.32 X | |||
Earnings Per Share | (8.70) X | |||
Number Of Employees | 77 | |||
Beta | 1.37 | |||
Market Capitalization | 4.13 M | |||
Total Asset | 97.65 M | |||
Retained Earnings | (85.59 M) | |||
Working Capital | 14.63 M | |||
Current Asset | 46.34 M | |||
Current Liabilities | 7.23 M | |||
Net Asset | 97.65 M |
About Medigus Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medigus Ltd ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medigus using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medigus Ltd ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Consideration for investing in Medigus Stock
If you are still planning to invest in Medigus Ltd ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medigus' history and understand the potential risks before investing.
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |